Special Issue "Pathogen-Host Interactions: Implications for Vaccine Design"
A special issue of Vaccines (ISSN 2076-393X).
Deadline for manuscript submissions: closed (31 October 2018)
Dr. Randy A. Albrecht
Department of Microbiology, Box 1124, Icahn School of Medicine at Mount Sinai, One Gustave L. Levy Place, New York, NY 10029-6574, USA
Website 1 | Website 2 | E-Mail
Interests: influenza virus; influenza virus vaccines; mucosal immunity; virus-host interactions; pathogenesis; emerging viruses; animal models
How can studies on host-pathogen interactions influence the development of vaccines? What are the implications of the coevolution of a pathogen with its host for vaccine development? The outcome of the interaction of the host with a pathogen dictates the clinical severity of disease resulting from infection by that pathogen. This same basic principle also applies to the development of vaccines based on live, attenuated versions of a pathogen. Recent advances in cell culture systems, including 3D cultures and organoids, and animal models, are instrumental in gaining insight into pathogenesis and host immune response to infection by a pathogen or immunization. An improved understanding of host-pathogen interactions will drive forward the development of vaccines.
This Special Issue of Vaccines will bring together a collection of reviews and peer-reviewed articles on cutting-edge research that is focused on detailing the implications of host-pathogen interactions or host-vaccine interactions on vaccine design and effectiveness. Importantly, this Special Issue also aims to address the implications of host-pathogen or host-vaccine interactions for the identification of correlates of protection induced by vaccination. Perspectives, review articles, and original research articles are invited from specialists in host-pathogen interactions, host-vaccine interactions, vaccine development, vaccine delivery, identification of immunogens, host immune response, and clinical and/or preclinical trials.
Dr. Randy Albrecht
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All papers will be peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Vaccines is an international peer-reviewed open access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 650 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- host-pathogen interactions
- host-pathogen coevolution
- host-vaccine interactions
- vaccine development
- immunogen design
- immune evasion
- mucosal immunity